A key trend seen in 2024 and recent years is the simplification of basket sizes, as countries look to streamline and simplify.

What more should China do to create a more enabling business environment for foreign investors? MOREL: As China approaches ...

Pharma is missing opportunities to maximise the benefits of applying a digital approach on a global scale, says Gregg Fisher. Managing for global impact continues to be a challenge for many ...

According to PEZA Board Resolution No. 25-050, the minimum size applies to pharma the minimum contiguous ... positioning the Philippines as a competitive player in the global pharmaceutical market,” ...

Investigators said that the OLE study showed Roche’s gantenerumab dropped the risk of developing Alzheimer's symptoms by 50%.

Incyte's revenues continues to grow, with full-year 2024 revenues reaching $4.2 billion, driven by JAKAFI and OPZELURA. Click ...

As growth opportunities continue to move away from the traditional pharmaceutical ... the sights of their expanding global footprint. In particular the private market and the continent's growing ...

Inside Coke's covert campaign to downplay the risks of sugary soda. A new book shows how the company misled America.

Eric Karas, Chief Commercial Officer, outlined the company's multi-pronged strategy to increase neffy adoption, focusing on education, payer coverage, and patient awareness. He noted that neffy ...